York Biotech Campus (YBC) it set to launch a brand-new, state-of-the-art Insect Quarantine Unit following a significant investment.
The specialist facility has been relocated and completely rebuilt within a vacant unit on the YBC site, enhancing the capabilities of long-standing occupier Fera Science Ltd.
Spanning 2,500 sq. ft., built to the highest industry standards and with sustainability in mind, the new unit provides Fera Science Ltd with a purpose-built environment to carry out advanced research and development on invertebrate quarantine pests as part of its remit in ensuring the UK’s biosecurity.
The launch marks a major step in YBC’s ongoing support for scientific innovation and providing world-class infrastructure for its occupiers. The facility enables Fera Science Ltd to expand its capabilities in insect research, including work that supports government policy objectives, biosecurity, food security targets, and environmental sustainability.
The unit is designed to house and study a wide range of invertebrate species under strict quarantine conditions. The unit plays a vital role in Fera Science Ltd’s work with the Department for Environment, Food and Rural Affairs (Defra), supporting research into invasive non-native species.
Axentia Biotech has managed the programme on behalf of YBC, providing an end-to-end service of laboratory design expertise with construction tender, procurement and management, to assist YBC in its provision of class-leading tenant facilities.
Liz Cashon, Estates Manager at York Biotech Campus, said: “We’re proud to be investing in this new Insect Quarantine Unit for Fera Science Ltd. It’s a vital facility that supports not only their scientific work but also national and international efforts in biosecurity and sustainable agriculture. At YBC, we’re committed to providing the infrastructure and support our tenants need to thrive, and this project is a great example of that in action.”
Phil Northing, Head of Science Strategy at Fera Science Ltd, added: “This new facility will significantly enhance our ability to carry out high-level insect research in a secure and controlled environment. It’s a key part of our long-term strategy to support sustainable food systems and protect the UK’s natural environment. We’re grateful to YBC for their continued support and investment in our shared vision.”
Simon Ward, MD of Axentia Biotech, said: “We’re delighted to have partnered with YBC and Fera Science Ltd on this project, delivering a suite of heavily serviced, high specification laboratories to support the vital scientific work being carried out on the Campus.”
The new Insect Quarantine Unit further strengthens YBC’s position as a leading centre for bioscience innovation in the UK and highlights the campus’s role in enabling cutting-edge research with real-world impact.
For more information about York Biotech Campus, please visit: https://yorkbiotechcampus.com/
